Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address
Urinary tract infections are among the most common reasons for prescribing antibiotics. Since conventional pathogen identification in the laboratory usually takes two to three days, initial treatment
Most malaria drugs are combination therapies based on artemisinin, an active ingredient derived from the medicinal plant Artemisia annua (sweet wormwood). The malaria parasite Plasmodium falciparum is
The World Neglected Tropical Diseases (NTD) Day on January 30 aims to raise awareness of diseases that affect millions of people worldwide but are usually overshadowed by other global health issues
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at
On February 23 and 24, 2026, experts from the German Center for Infection Research (DZIF) and the Paul-Ehrlich-Society for Infection Therapy (PEG) will meet at the Maritim Hotel in Bonn for their
Diagnosis of pulmonary tuberculosis (TB) has so far been based primarily on sputum samples. However, not all patients are able to produce sufficient sputum. A recently published prospective study
Resistance to antibiotics is increasing worldwide. This also applies to drugs that are central to the treatment of tuberculosis (TB), such as bedaquiline. An international panel of experts from 32
The Cologne-based research project "INNOPAK", which focuses on developing innovative precision antibodies against infections with antibiotic-resistant Pseudomonas aeruginosa-bacteria, will receive
